(+) -DHMEQ
(+) -DHMEQ is an activator of antioxidant transcription factor Nrf2. (+) -DHMEQ is the enantiomer of (-) -DHMEQ. (-) -DHMEQ inhibits NF-kB than its enantiomer (+) -DHMEQ.
Product Specifications
CAS Number
287194-41-6
Product Name Alternative
(1R,2R,6R) -Dehydroxymethylepoxyquinomicin; (1R,2R,6R) -DHMEQ
UNSPSC
12352005
Target
Keap1-Nrf2
Type
Reference compound
Related Pathways
NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/__addition__-DHMEQ.html
Purity
98.61
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NC([C@@H](O)[C@@]1([H])O[C@@]21[H])=CC2=O)C3=CC=CC=C3O
Molecular Formula
C13H11NO5
Molecular Weight
261.23
References & Citations
[1]Niitsu Y, et al. Chemoenzymatic synthesis of (2R,3R,4R) -dehydroxymethylepoxyquinomicin (DHMEQ), a newactivator of antioxidant transcription factor Nrf2. Org Biomol Chem. 2011 Jun 21;9 (12) :4635-41.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC431447 20 µg
Calcitonin receptor (CALCR) (NM_001164737) Human Over-expression Lysate
Sign In for Pricing
View Details 
